Home » Newsletters » BioWorld Science

BioWorld Science

July 1, 2013

View Archived Issues

The identification of biomarkers to predict the predisposition to depression following child birth

The first ligand-inducible fluorophore for the detection of a specific human clinical biomarker

Novel drug candidate for L-Dopa-induced dyskinesia

IL12RB1 is identified as a novel candidate gene underlying ALPS type III

Dompe and SatRx set to develop drug against liver transplant rejection

VX-509 modulates markers of rheumatoid arthritis disease activity

GE Healthcare presents new radiotracers for brain imaging

Iron in gut lavage fluid is increased in patients with colon cancer

VivaMab and ADC Therapeutics enter licensing agreement for ADC candidate

Amicus to develop chaperone-advanced replacement therapy for MPS I

Preclinical investigations of the safety and efficacy of drugs for the treatment of tinnitus

MediciNova to conduct preclinical studies of MN-001 for NASH

Phase I atopic dermatitis study initiated in Japan

Sucampo receives milestone payment for Amitiza launch

MorphoSys and Celgene create alliance to develop MOR-202 for multiple myeloma

Pergamum reports follow-up data from phase II PXL-01 study

Forest Laboratories reports phase III data for nebivolol and valsartan

European marketing authorization for Brinavess transferred to Cardiome

Imperial Innovations presents new agents for protozoal infections

Novel kappa receptor antagonists disclosed by Research Triangle Institute

Chiesi Farmaceutici divulges new protein kinase p38 inhibitors

First approval achieved for gout and hyperuricemia therapeutic in Japan

Novel BACE1 inhibitors patented by Janssen Pharmaceutica

Subcutaneous Orencia approved in Japan

Bonviva approved in Japan for osteoporosis